Status:
COMPLETED
Observing the Curative Effect of Assisted Reproduction by TCM Multi-channel Interventional Therapy
Lead Sponsor:
Chengdu University of Traditional Chinese Medicine
Conditions:
Failure After Assisted Reproductive Technology
Eligibility:
FEMALE
24-43 years
Phase:
PHASE2
Brief Summary
Objective: To evaluate the curative effect of TCM multi-channel interventional therapy on women with ART Failure; to compare the curative effect of the dual therapy and triple therapy on women with AR...
Detailed Description
Objective: To evaluate the curative effect of TCM multi-channel interventional therapy on women with ART Failure; to compare the curative effect of the dual therapy and triple therapy on women with AR...
Eligibility Criteria
Inclusion
- People aged 20 to 45
- People with IVF - ET indications
- People from Reproductive Center of West China second University Hospital of Sichuan University (West China Women's and Children's Hospital of Sichuan University) with long plan for IVE - ET Failure and then accept the secondary IVF-ET
- People who conform to the standard of syndrome differentiation in TCM: kidney deficiency and liver depression and blood stasis
- People with normal basic sex hormone levels
- People who have recognized and voluntarily signed the informed consent. NOTICE: People who conform to the above 6 items can be included.
Exclusion
- People don't meet the inclusion criteria
- The husband with less sperm and weak sperm seriously
- People who have drug allergy or allergic constitution
- People with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, etc. And mentally disordered patients
- People who are complicated by acute infectious diseases and organic diseases
- People have confirmed diagnosis malformed reproductive organs, reproductive system inflammation and tumors upon examination
- People suffer from hereditary disease which is not suitable for fertility regulated in "maternal and infant health care law"
- People who have the serious bad habits such as drug use
- People who have contacted with birth defects rays, poison, drugs to a certain number and being in effect; NOTICE: People who conform to any of the terms above 9 will be ruled out.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02303665
Start Date
November 1 2014
End Date
March 1 2016
Last Update
March 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China second University Hospital of Sichuan University
Chengdu, Sichuan, China, 610041